Korro Bio (KRRO) Short-term Investments (2019 - 2026)

Korro Bio (KRRO) has 8 years of Short-term Investments data on file, last reported at $52.3 million in Q1 2026.

• Quarterly Short-term Investments rose 2.88% year-over-year to $52.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.3 million (up 2.88% YoY) and the FY2025 annual result came in at $53.3 million, down 24.3% from the prior year.
• Short-term Investments declined to $52.3 million in Q1 2026, from $53.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $73.8 million in Q3 2024 to a low of $600000.0 in Q4 2022.
• A 5-year average of $45.6 million and a median of $54.4 million in 2022 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments slumped 98.83% — and 2024, when it jumped 1857.0%.
• Tracing KRRO's Short-term Investments over 5 years: stood at $600000.0 in 2022, then soared by 500.0% to $3.6 million in 2023, then jumped by 1857.0% to $70.5 million in 2024, then declined by 24.3% to $53.3 million in 2025, then dropped by 1.99% to $52.3 million in 2026.
• The last three Short-term Investments figures came in at $52.3 million (Q1 2026), $53.3 million (Q4 2025), and $68.3 million (Q3 2025), per Business Quant data.